• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Finland·Technology·TIETOS.ST
Share

TietoEVRY Oyj Stocks

SEK 213.6Last Updated 12.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

SEK 2.30B

SEK 213.6
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

TietoEVRY Oyj, a leading technology company established in 1968 and headquartered in Espoo, Finland, delivers a comprehensive suite of software and digital services. The firm, which rebranded from Tieto Oyj in December 2019, structures its operations across six primary segments. Its Digital Consulting division provides strategic advice on business and technology, alongside system integration and ongoing application management. The Cloud & Infra segment offers automated solutions, including managed cloud services, robust security, and end-user support, augmented by expert guidance on cloud migration and transformation. The Industry Software segment develops specialized software products tailored for mission-critical processes within the public, healthcare, welfare, forestry, energy, and oil and gas sectors. For financial institutions, the Financial Services Solutions segment delivers real-time systems for payments, card processing, wealth management, and credit, in addition to business process outsourcing (BPO). The International Operations segment oversees the company's global business activities. Lastly, the Product Development Services segment concentrates on software research and development (R&D), with a significant focus on the telecommunications industry and expansion into new areas such as automotive, serving companies in communications infrastructure, consumer electronics, semiconductors, and the automotive sector. TietoEVRY maintains a substantial operational presence in Finland, Sweden, Norway, Austria, the Baltic countries, and Russia, alongside broader international markets.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA, tradin

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.10.2026 02:46

The headquarters of the world's most valuable oil company was hit by a missile strike

14.10.2026 01:32

Bank of America was fined $1.2 billion for violations related to money laundering

14.10.2026 01:00

Goldman Sachs announced the emergence of two competing AI ecosystems in the U.S. and China

14.10.2026 00:28

Truist is among the top bulls on Meta: it predicts its stock will rise another 35%

13.10.2026 23:00

BioNTech reported another setback in the development of cancer drugs. Its stock plummeted

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026